CIK: 0001056807 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value ($000): $893,065 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 3,420,562 | $83,393 | 9.3% | $10.14 | — | COM | 04269X105 |
| — | MERUS N V | 4,539,913 | $67,055 | 7.5% | $19.33 | — | COM | N5749R100 |
| — | BLUEPRINT MEDICINES CORP | 564,965 | $45,225 | 5.1% | $25.16 | — | COM | 09627Y109 |
| KURA | KURA ONCOLOGY INC | 2,495,156 | $41,395 | 4.6% | $12.32 | +25.1% | COM | 50127T109 |
| — | FIVE PRIME THERAPEUTICS INC | 3,064,346 | $41,062 | 4.6% | $14.45 | — | COM | 33830X104 |
| ACIU | AC IMMUNE SA | 7,455,534 | $37,650 | 4.2% | $7.45 | -14.6% | SHS | H00263105 |
| RCUS | ARCUS BIOSCIENCES INC | 2,810,223 | $35,100 | 3.9% | $13.30 | -18.4% | COM | 03969F109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $32,763 | 3.7% | $2.67 | -45.3% | COM | 45665G303 |
| — | MIRATI THERAPEUTICS INC | 431,700 | $31,644 | 3.5% | $49.30 | — | COM | 60468T105 |
| CYTK | CYTOKINETICS INC | 3,801,817 | $30,757 | 3.4% | $10.41 | -29.4% | COM NEW | 23282W605 |
| — | ARQULE INC | 6,308,746 | $30,219 | 3.4% | $1.85 | — | COM | 04269E107 |
| REPL | REPLIMUNE GROUP INC | 1,606,817 | $24,456 | 2.7% | $15.30 | -18.5% | COM | 76029N106 |
| XOMA | XOMA CORP DEL | 1,769,029 | $21,901 | 2.5% | $6.70 | +104.1% | COM NEW | 98419J206 |
| — | MOLECULAR TEMPLATES INC | 3,579,140 | $20,795 | 2.3% | $5.50 | — | COM | 608550109 |
| — | DICERNA PHARMACEUTICALS INC | 1,400,956 | $20,524 | 2.3% | $14.97 | — | COM | 253031108 |
| — | CALITHERA BIOSCIENCES INC | 3,023,482 | $20,378 | 2.3% | $4.97 | — | COM | 13089P101 |
| — | CHEMOCENTRYX INC | 1,464,515 | $20,342 | 2.3% | $8.94 | — | COM | 16383L106 |
| XENE | XENON PHARMACEUTICALS INC | 1,788,774 | $18,174 | 2.0% | $9.34 | -9.2% | COM | 98420N105 |
| — | CONCERT PHARMACEUTICALS INC | 1,385,487 | $16,723 | 1.9% | $13.82 | — | COM | 206022105 |
| ANAB | ANAPTYSBIO INC | 220,265 | $16,090 | 1.8% | $23.32 | +196.1% | COM | 032724106 |
| — | GALMED PHARMACEUTICALS LTD | 1,878,508 | $15,347 | 1.7% | $11.58 | — | SHS | M47238106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,123,255 | $14,119 | 1.6% | $9.71 | -9.1% | COM | 74366E102 |
| — | PIERIS PHARMACEUTICALS INC | 4,058,385 | $13,596 | 1.5% | $4.05 | — | COM | 720795103 |
| — | MERSANA THERAPEUTICS INC | 2,500,000 | $13,150 | 1.5% | $5.26 | — | COM | 59045L106 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,198,000 | $12,879 | 1.4% | $14.78 | 0.0% | COM | 23284F105 |
| — | BIOLINERX LTD | 25,995,575 | $11,178 | 1.3% | $1.01 | — | SPONSORED ADS | 09071M106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,987,669 | $10,435 | 1.2% | $8.22 | -30.6% | COM | 87164F105 |
| — | VERASTEM INC | 3,513,994 | $10,401 | 1.2% | $3.19 | — | COM | 92337C104 |
| ARGX | ARGENX SE | 80,868 | $10,096 | 1.1% | $76.85 | — | SPONSORED ADR | 04016X101 |
| — | FORWARD PHARMA A/S | 8,480,079 | $10,006 | 1.1% | $5.84 | — | SPONSORED ADR | 34986J105 |
| — | SPRING BK PHARMACEUTICALS INC | 951,701 | $9,983 | 1.1% | $13.40 | — | COM | 849431101 |
| — | EIGER BIOPHARMACEUTICALS INC | 675,000 | $9,437 | 1.1% | $10.16 | — | COM | 28249U105 |
| — | VBI VACCINES INC | 4,722,572 | $8,831 | 1.0% | $3.19 | — | COM NEW | 91822J103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,109,342 | $8,480 | 0.9% | $9.44 | -55.3% | COM | 221015100 |
| — | MEI PHARMA INC | 2,698,755 | $8,285 | 0.9% | $3.94 | — | COM NEW | 55279B202 |
| — | ALPINE IMMUNE SCIENCES INC | 1,201,717 | $8,244 | 0.9% | $9.40 | — | COM | 02083G100 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $6,723 | 0.8% | $3.77 | — | COM NEW | 12648L601 |
| — | ALBIREO PHARMA INC | 200,500 | $6,458 | 0.7% | $32.57 | — | COM | 01345P106 |
| VYGR | VOYAGER THERAPEUTICS INC | 310,299 | $5,939 | 0.7% | $19.14 | — | COM | 92915B106 |
| SPRO | SPERO THERAPEUTICS INC | 460,706 | $5,902 | 0.7% | $12.08 | -12.1% | COM | 84833T103 |
| OVID | OVID THERAPEUTICS INC | 3,293,000 | $5,829 | 0.7% | $2.50 | 0.0% | COM | 690469101 |
| — | ERYTECH PHARMA | 625,000 | $4,750 | 0.5% | $22.02 | — | SPONSORED ADR | 29604W108 |
| — | GENOCEA BIOSCIENCES INC | 7,828,243 | $4,619 | 0.5% | $0.88 | — | COM | 372427104 |
| — | CIDARA THERAPEUTICS INC | 1,710,684 | $4,533 | 0.5% | $4.24 | — | COM | 171757107 |
| — | ONCOMED PHARMACEUTICALS INC | 4,108,815 | $4,273 | 0.5% | $8.64 | — | COM | 68234X102 |
| — | SUNESIS PHARMACEUTICALS INC | 2,287,860 | $2,780 | 0.3% | $2.76 | — | COM PAR | 867328700 |
| — | VICAL INC | 2,279,059 | $2,735 | 0.3% | $1.56 | — | COM NEW | 925602203 |
| — | REALM THERAPEUTICS PLC | 612,889 | $2,409 | 0.3% | $3.53 | — | SPONSORED ADS | 75606L103 |
| — | SURFACE ONCOLOGY INC | 451,850 | $2,155 | 0.2% | $13.55 | — | COM | 86877M209 |
| — | ESSA PHARMA INC | 580,368 | $1,991 | 0.2% | $3.75 | — | COM NEW | 29668H708 |
| — | REGULUS THERAPEUTICS INC | 1,051,940 | $1,073 | 0.1% | $0.93 | — | COM NEW | 75915K200 |
| — | CONTRAFECT CORP | 1,898,990 | $755 | 0.1% | $1.14 | — | COM | 212326102 |
| XNCR | XENCOR INC | 904 | $28 | 0.0% | $26.15 | +27.3% | COM | 98401F105 |